CLINICAL_TRIALS
research
· 2026-03-04
Clinical Trial Update: Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care [Phase 3]
Summary
Phase 3 trial evaluating immediate radiation with GammaTile at glioblastoma excision versus standard of care; currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GT Medical Technologies, Inc. | Conditions: Glioblastoma | Phase 3 | Status: RECRUITING